OVID Earnings Ovid Therapeutics Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–19 of 19
| Q3 2024 | 2024-09-30 | -0.24 | 2024-11-12 | 10-Q |
| Q2 2024 | 2024-06-30 | -0.04 | 2024-08-13 | 10-Q |
| Q1 2024 | 2024-03-31 | -0.17 | 2024-05-14 | 10-Q |
| FY 2023 | 2023-12-31 | -0.74 | 2024-03-08 | 10-K |
| Q3 2024 | 2023-09-30 | -0.52 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.37 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.19 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -0.77 | 2024-03-08 | 10-K |
| Q3 2023 | 2022-09-30 | -0.61 | 2023-11-03 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.44 | 2023-08-04 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.23 | 2023-05-05 | 10-Q |
| FY 2022 | 2021-12-31 | 1.76 | 2023-03-13 | 10-K |
| Q3 2022 | 2021-09-30 | 2.14 | 2022-11-08 | 10-Q |
| Q2 2022 | 2021-06-30 | 2.30 | 2022-08-09 | 10-Q |
| Q1 2022 | 2021-03-31 | 2.53 | 2022-05-10 | 10-Q |
| FY 2021 | 2020-12-31 | -1.39 | 2022-03-15 | 10-K |
| Q3 2021 | 2020-09-30 | -1.04 | 2021-11-10 | 10-Q |
| Q2 2021 | 2020-06-30 | -0.77 | 2021-08-16 | 10-Q |
| Q1 2021 | 2020-03-31 | -0.37 | 2021-05-13 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.